Goldman Sachs’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$476K Sell
126,390
-32,253
-20% -$174K ﹤0.01% 5630
2025
Q4
$1.26M Buy
158,643
+50,388
+47% +$322K ﹤0.01% 4956
2025
Q3
$372K Buy
108,255
+47,977
+80% +$179K ﹤0.01% 5659
2025
Q2
$249K Sell
60,278
-36,512
-38% -$122K ﹤0.01% 5549
2025
Q1
$232K Sell
96,790
-46,583
-32% -$131K ﹤0.01% 5574
2024
Q4
$522K Buy
143,373
+54,713
+62% +$249K ﹤0.01% 5230
2024
Q3
$559K Buy
88,660
+53,603
+153% +$361K ﹤0.01% 4985
2024
Q2
$234K Buy
+35,057
New +$207K ﹤0.01% 5192
2023
Q3
Sell
-26,100
Closed -$216K 5822
2023
Q2
$216K Sell
26,100
-4,577
-15% -$41.2K ﹤0.01% 5151
2023
Q1
$268K Buy
30,677
+12,215
+66% +$136K ﹤0.01% 5174
2022
Q4
$225K Sell
18,462
-176,244
-91% -$1.68M ﹤0.01% 5250
2022
Q3
$1.24M Buy
194,706
+4,885
+3% +$41.3K ﹤0.01% 4369
2022
Q2
$1.71M Buy
+189,821
New +$1.67M ﹤0.01% 4181
2021
Q4
Sell
-37,728
Closed -$856K 6677
2021
Q3
$856K Buy
+37,728
New +$1.24M ﹤0.01% 4870

Other funds holding SGHT

Goldman Sachs's SGHT Position: Q1 2026 in Review

Goldman Sachs reduced its Sight Sciences (SGHT) stake by 20% in Q1 2026, selling an estimated $174K and leaving 126,390 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #5630.

Goldman Sachs first reported a position in SGHT in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.71M in Q2 2022. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Goldman Sachs held 126,390 shares of Sight Sciences worth $476K as of Q1 2026.
  • Goldman Sachs sold 32,253 Sight Sciences shares in Q1 2026, an estimated $174K.
  • Sight Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5630 holding.
  • Goldman Sachs first reported a position in Sight Sciences in Q3 2021 and has held it in 14 quarters since.
  • Goldman Sachs's Sight Sciences position peaked at $1.71M in Q2 2022.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.